Matches in Wikidata for { <http://www.wikidata.org/entity/Q83362189> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q83362189 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q83362189 description "im Januar 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83362189 description "scientific article published on 30 January 2012" @default.
- Q83362189 description "wetenschappelijk artikel" @default.
- Q83362189 description "наукова стаття, опублікована в січні 2012" @default.
- Q83362189 name "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 name "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 type Item @default.
- Q83362189 label "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 label "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 prefLabel "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 prefLabel "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 P1433 Q83362189-1C243691-D04D-4CC5-8A92-9924A2A16FB0 @default.
- Q83362189 P1476 Q83362189-6233BA09-D18A-46D8-A92C-0E978A7A8831 @default.
- Q83362189 P2093 Q83362189-289D4682-60D2-4AC6-BBFD-6977512B4EB8 @default.
- Q83362189 P2093 Q83362189-30B7437D-FAAD-4508-B23E-5C7533858AC1 @default.
- Q83362189 P2093 Q83362189-66D88901-649D-4536-9765-B029DC8037AD @default.
- Q83362189 P2093 Q83362189-B4A58CE3-91DD-49C0-B7FB-FBB868E6988B @default.
- Q83362189 P2093 Q83362189-BBEFC72C-71AC-48B6-B98F-5AA28F9A21B3 @default.
- Q83362189 P2860 Q83362189-24009E1E-FD95-45F5-AE65-A162D85DB7DC @default.
- Q83362189 P2860 Q83362189-35CD080B-F60D-49E4-AE77-DE3D334AADB0 @default.
- Q83362189 P2860 Q83362189-3645C7F5-4392-41B8-934C-1E894CD3CEDD @default.
- Q83362189 P2860 Q83362189-4404B048-C4A3-4267-A137-D2DBBAAC7FF6 @default.
- Q83362189 P2860 Q83362189-47D476AB-A306-408B-91E7-CBA72CB3D358 @default.
- Q83362189 P2860 Q83362189-7A637BFC-EC85-418E-90C2-CAA5621C8914 @default.
- Q83362189 P2860 Q83362189-927A454D-ACF7-4E58-8AFB-1490D3CC9D87 @default.
- Q83362189 P2860 Q83362189-B294531C-A0B5-4174-AC31-43EA56F4566A @default.
- Q83362189 P2860 Q83362189-BD0312AC-6EBD-4416-9D35-CB3633A8DE30 @default.
- Q83362189 P2860 Q83362189-C36B4758-A96F-4832-9B56-0B50A7E5D538 @default.
- Q83362189 P2860 Q83362189-D544ED95-7763-4517-B725-BF538C7461B7 @default.
- Q83362189 P2860 Q83362189-DC808B6D-AB72-4F59-A210-9D1B25623A37 @default.
- Q83362189 P2860 Q83362189-DFDAB5FF-3C9E-4020-B65A-23EA8E2F9AA4 @default.
- Q83362189 P304 Q83362189-79C39F0B-2D65-4742-BFF8-A3E333376C8C @default.
- Q83362189 P31 Q83362189-6B2CC5C0-DDDD-4CA0-8C03-FA3254EEE846 @default.
- Q83362189 P356 Q83362189-DDBF0EF1-9789-4411-A0DC-5970C1A1F6DB @default.
- Q83362189 P433 Q83362189-CD4CB256-1866-4D9D-B68F-8808433A1B06 @default.
- Q83362189 P478 Q83362189-E770953D-CA4A-4268-B65A-B65957559266 @default.
- Q83362189 P50 Q83362189-1FE8ED18-45D3-42C4-B28B-583FD0288E0E @default.
- Q83362189 P50 Q83362189-B61E5515-8449-4441-A735-2632EB0143C8 @default.
- Q83362189 P50 Q83362189-FFCFF564-8760-491A-A6BB-25811FBA7F02 @default.
- Q83362189 P577 Q83362189-3E66E1B9-1096-4512-B291-6036503C06BB @default.
- Q83362189 P698 Q83362189-87D5B7C2-F38F-4139-8FDF-86BD5094B3AE @default.
- Q83362189 P921 Q83362189-42246292-B992-4530-995B-81FAC3D57AF3 @default.
- Q83362189 P932 Q83362189-984A1F08-59C8-4B4D-AD58-E095C638890F @default.
- Q83362189 P356 J.1464-410X.2011.10875.X @default.
- Q83362189 P698 22289613 @default.
- Q83362189 P1433 Q4835773 @default.
- Q83362189 P1476 "Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer" @default.
- Q83362189 P2093 "Ashley E Ross" @default.
- Q83362189 P2093 "Bruce J Trock" @default.
- Q83362189 P2093 "Edward M Schaeffer" @default.
- Q83362189 P2093 "Phillip M Pierorazio" @default.
- Q83362189 P2093 "Zhaoyong Feng" @default.
- Q83362189 P2860 Q30010961 @default.
- Q83362189 P2860 Q34330041 @default.
- Q83362189 P2860 Q34534815 @default.
- Q83362189 P2860 Q36328870 @default.
- Q83362189 P2860 Q37815817 @default.
- Q83362189 P2860 Q39931375 @default.
- Q83362189 P2860 Q42624439 @default.
- Q83362189 P2860 Q44697461 @default.
- Q83362189 P2860 Q45133435 @default.
- Q83362189 P2860 Q45216796 @default.
- Q83362189 P2860 Q46472557 @default.
- Q83362189 P2860 Q62778223 @default.
- Q83362189 P2860 Q80487606 @default.
- Q83362189 P304 "651-657" @default.
- Q83362189 P31 Q13442814 @default.
- Q83362189 P356 "10.1111/J.1464-410X.2011.10875.X" @default.
- Q83362189 P433 "5" @default.
- Q83362189 P478 "110" @default.
- Q83362189 P50 Q114718059 @default.
- Q83362189 P50 Q116856310 @default.
- Q83362189 P50 Q2057508 @default.
- Q83362189 P577 "2012-01-30T00:00:00Z" @default.
- Q83362189 P698 "22289613" @default.
- Q83362189 P921 Q181257 @default.
- Q83362189 P932 "6489446" @default.